Indivior Pharmaceuticals, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:INDV) | MetaTrader

Apri il grafico completo Full chart

Indivior Pharmaceuticals, Inc. - Common Stock

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

Notizie

Goldman Sachs Hits Record High, Leads 15 Newcomers To Best Growth Stock Lists

FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study

CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up

AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication

Is Molina Healthcare Worth Buying at a Premium 26.83X P/E Valuation?

Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

Beat the Market the Zacks Way: ORIX, Starbucks, Alphabet in Focus

AGIO's Pyrukynd Gets Approval for Thalassemia in Europe

CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity

BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data